Publications 2024
Low tumor interleukin-1? expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study.
Pulmonology nn, nn (2024) [10.1016/j.pulmoe.2024.03.003]
BibTeX |
EndNote:
XML,
Text |
RIS
Addition of inflammation-related biomarkers to the CAIDE model for risk prediction of all-cause dementia, Alzheimer's disease and vascular dementia in a prospective study.
Immunity & ageing 21(1), 23 (2024) [10.1186/s12979-024-00427-2]
BibTeX |
EndNote:
XML,
Text |
RIS
Neurological complications of the central nervous system after allogeneic stem cell transplantation: the role of TA-TMA as a potential underreported cause.
Transplantation and cellular therapy nn, nn (2024) [10.1016/j.jtct.2024.03.017]
BibTeX |
EndNote:
XML,
Text |
RIS
Capturing COPD heterogeneity: anomaly detection and parametric response mapping comparison for phenotyping on chest computed tomography.
Frontiers in medicine 11, 1360706 (2024) [10.3389/fmed.2024.1360706]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Would initiating colorectal cancer screening from age of 45 be cost-effective in Germany? An individual-level simulation analysis.
Frontiers in Public Health 12, 1307427 (2024) [10.3389/fpubh.2024.1307427]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [18F]FDG PET/CT predicts survival in multiple myeloma.
European journal of nuclear medicine and molecular imaging nn, nn (2024) [10.1007/s00259-024-06668-z]
BibTeX |
EndNote:
XML,
Text |
RIS
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial.
Hematology 29(1), 2320006 (2024) [10.1080/16078454.2024.2320006]
BibTeX |
EndNote:
XML,
Text |
RIS
Statistical plasmode simulations-Potentials, challenges and recommendations.
Statistics in medicine 43(9), 1804-1825 (2024) [10.1002/sim.10012]
BibTeX |
EndNote:
XML,
Text |
RIS
Understanding metric-related pitfalls in image analysis validation.
Nature methods 21(2), 182 - 194 (2024) [10.1038/s41592-023-02150-0]
BibTeX |
EndNote:
XML,
Text |
RIS
Metrics reloaded: recommendations for image analysis validation.
Nature methods 21(2), 195 - 212 (2024) [10.1038/s41592-023-02151-z]
BibTeX |
EndNote:
XML,
Text |
RIS
A diagnostic phase III/IV seamless design to investigate the diagnostic accuracy and clinical effectiveness using the example of HEDOS and HEDOS II.
Statistical methods in medical research 33(3), 433-448 (2024) [10.1177/09622802241227951]
BibTeX |
EndNote:
XML,
Text |
RIS
Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases.
Acta dermato-venereologica 104, adv13381 - (2024) [10.2340/actadv.v104.13381]
BibTeX |
EndNote:
XML,
Text |
RIS
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial.
The lancet / Haematology 11(2), e101 - e113 (2024) [10.1016/S2352-3026(23)00366-6]
BibTeX |
EndNote:
XML,
Text |
RIS
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts.
Leukemia 38(2), 389-392 (2024) [10.1038/s41375-024-02143-8]
BibTeX |
EndNote:
XML,
Text |
RIS
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study.
Journal for ImmunoTherapy of Cancer 12(1), e007635 (2024) [10.1136/jitc-2023-007635]
BibTeX |
EndNote:
XML,
Text |
RIS
Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary.
Clinical chemistry 70(1), 297 - 306 (2024) [10.1093/clinchem/hvad180]
BibTeX |
EndNote:
XML,
Text |
RIS
Robust incorporation of historical information with known type I error rate inflation.
Biometrical journal 66(1), e2200322 (2024) [10.1002/bimj.202200322]
BibTeX |
EndNote:
XML,
Text |
RIS
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients.
Leukemia 38(3), 640-647 (2024) [10.1038/s41375-023-02105-6]
BibTeX |
EndNote:
XML,
Text |
RIS
Onset time and characteristics of post-procedural bleeding after endoscopic resection of colorectal lesions: a multicenter retrospective study.
Digestive diseases 42(1), 78-86 (2024) [10.1159/000534109]
BibTeX |
EndNote:
XML,
Text |
RIS
CpG-biomarkers in tumor tissue and prediction models for the survival of colorectal cancer: a systematic review and external validation study.
Critical reviews in oncology, hematology 193, 104199 (2024) [10.1016/j.critrevonc.2023.104199]
BibTeX |
EndNote:
XML,
Text |
RIS
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
European urology 85(2), 105-111 (2024) [10.1016/j.eururo.2023.09.027]
BibTeX |
EndNote:
XML,
Text |
RIS
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma.
Journal of clinical oncology 42(1), 26-37 (2024) [10.1200/JCO.23.01696]
BibTeX |
EndNote:
XML,
Text |
RIS
Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
Pharmaceutical statistics 23(1), 4-19 (2024) [10.1002/pst.2334]
BibTeX |
EndNote:
XML,
Text |
RIS
Weakly Supervised MRI Slice-Level Deep Learning Classification of Prostate Cancer Approximates Full Voxel- and Slice-Level Annotation: Effect of Increasing Training Set Size.
Journal of magnetic resonance imaging 59(4), 1409-1422 (2024) [10.1002/jmri.28891]
BibTeX |
EndNote:
XML,
Text |
RIS
Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Haematologica 109(1), 72-83 (2024) [10.3324/haematol.2023.282912]
BibTeX |
EndNote:
XML,
Text |
RIS